文献速递临床免疫分子诊断

Elecsys HIV Duo检测的临床性能评估:从HIV筛查到急性和非急性HIV感染检测

Clinical performance evaluation of an HIV Duo assay: From HIV screening to acute and non-acute HIV infection detection.
PubMed 文献 · Clin Chim Acta · 2024-09-04

本研究评估Elecsys HIV Duo检测用于HIV初筛和急性HIV感染检测的临床性能。筛查人群含111383份样本,特异性99.91%(95%CI: 99.89%, 99.93%),PPV为0.8516(95%CI: 0.8225, 0.8776)。确诊人群836例HIV患者中14例急性HIV感染仅HIV Ag阳性且WB确认率0%。该检测适合初筛并可整合入新型实验室HIV检测流程。

要点

  • Elecsys HIV Duo用于初筛特异性99.91%,PPV为0.8516。
  • 836例HIV患者中14例急性感染仅Ag阳性,WB确认率0%。
  • HIV Duo Ab和Ag的COI中位数在Ag+Ab-、Ag-Ab+和Ag+Ab+亚组间显著不同。

核心结论

  • Elecsys HIV Duo检测适合用于HIV初筛,并可整合入新型实验室HIV检测流程以提高中国临床实践中急性HIV感染的检出。

研究设计与样本

  • 研究于2022年4月至2023年4月开展,涉及两个人群;筛查人群获取2021年1月至2021年6月初次筛查的HIV Duo、HIV抗原和HIV抗体结果;确诊HIV人群检测2016年11月至2023年3月的回顾性样本。

主要发现

  • HIV筛查人群包含来自真实世界筛查项目的111383份样本,检测特异性为99.91%(95%CI: 99.89%, 99.93%),PPV为0.8516(95%CI: 0.8225, 0.8776)。
  • 确诊HIV人群纳入836例HIV患者,包括14例仅HIV Ag阳性的急性HIV感染患者,其Western Blot确认率为0%。
  • HIV Duo Ab和Ag的数值截断指数(COI)比值中位数(IQR)在Ag+Ab-、Ag-Ab+和Ag+Ab+亚组间显著不同。

临床怎么用

  • Elecsys HIV Duo可用于HIV初筛,并可整合入新型实验室HIV检测流程以改善急性HIV感染的检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evaluating the clinical performance of Elecsys HIV Duo assay for primary human immunodeficiency virus (HIV) screening and acute HIV infection detection. METHODS: This study was conducted from April 2022 to April 2023 and involved two distinct populations. For the HIV screening population, three HIV Duo results [HIV Duo, HIV antigen (Ag), and HIV antibody (Ab)] in primary screening were obtained (January 2021 to June 2021). In the diagnosed HIV population, retrospective samples from November 2016 to March 2023 were measured. RESULTS: The HIV screening population included 111,383 samples from a real-world screening program. The assay demonstrated a specificity of 99.91 % (95 % CI: 99.89 %, 99.93 %) and a PPV of 0.8516 (95 % CI: 0.8225, 0.8776). Regarding the diagnosed HIV population, 836 HIV patients were enrolled, including 14 acute HIV infectious patients with only HIV Ag + and a Western Blot (WB) confirmation rate of 0 %. The median (IQR) of the numeric cut-off index (COI) ratios of HIV Duo Ab and Ag significantly differed among the Ag + Ab-, Ag-Ab+, and Ag + Ab + subgroups. CONCLUSION: The Elecsys HIV Duo assay is suitable for primary HIV screening and can be integrated into a novel laboratory HIV testing algorithm to improve acute HIV detection in Chinese clinical practice. ABBREVIATIONS: HIV, Human immunodeficiency virus; AIDS, acquired immunodeficiency syndrome; Ag, antigen; Ab, antibody; WB, Western Blot; COI, numeric cut-off index; CI, confidence interval; NAT, nucleic acid tests; EDC, electronic data capture systems; CDC, Chinese Centers for Disease Control and Prevention; IQR, interquartile range; PPV, positive predictive value; HCV, hepatitis C virus; HBV, hepatitis B virus; CI, confidence interval; ND, not able to define; F, female; M, male.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Liu X, Wu C, Yuan Y, et al. Clinical performance evaluation of an HIV Duo assay: From HIV screening to acute and non-acute HIV infection detection. Clin Chim Acta. 2024. PMID: 39241902. doi:10.1016/j.cca.2024.119949

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。